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Edited by Miguel De la RosaAbstract Circular dichroism (CD) and NMR spectroscopy
were used to study the conformational properties of two synthetic
peptides, D82–R101 and D82–I109, encompassing the caveolin
scaﬀolding domain (D82–R101), in the presence of dod-
ecylphosphocholine (DPC) micelles. Our data show that a stable
helical conformation of the caveolin scaﬀolding domain in a
membrane mimicking system is only obtained for the peptide
including the L102–I109 hydrophobic stretch, a part of the cave-
olin intra-membrane domain. Through chemical shift variations,
an ensemble of six residues of the D82–L109 peptide, mainly lo-
cated in the V94TKYWFYR101 motif were found to detect the
presence of phosphatidylserine solubilized in DPC micelles.
Our results constitute a ﬁrst step for elucidating at a residue level
the conformational properties of the central region of the caveo-
lin-1 protein.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Caveolae refer to ﬂask-shaped invaginations of the plasma
membrane associated with a large number of biological func-
tions [1 and references therein]. In particular, they serve to
compartmentalize numerous proteins involved in signal trans-
duction pathways. Caveolae constitute micro-domains en-
riched in cholesterol and sphingolipids, containing a speciﬁc
membrane protein, the caveolin. Numerous data have shown
that caveolins are not only structural components of caveolae
but are also able to interact with signalling proteins, tran-
siently sequestered in caveolae, and to modulate their activity
[2]. Overall, it is clear that essential interaction networksAbbreviations: CD, circular dichroism; CRAC, cholesterol recognition
amino-acid consensus sequence; CSD, caveolin scaﬀolding domain;
CSI, chemical shift index; DSS, dimethylsilapentane-sulfonic acid,
sodium salt; DPC, dodecylphosphocholine; HSQC, heteronuclear
single quantum correlated spectroscopy; MALDI/TOF, matrix-
assisted laser desorption ionization time-of-ﬂight; NOESY, nuclear
Overhauser eﬀect spectroscopy; POPS, 1-palmitoyl-2-oleoyl-3-glycero-
phosphatidylserine; TFE, triﬂuoroethyl alcohol; TOCSY, total corre-
lated spectroscopy
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doi:10.1016/j.febslet.2006.08.075involving sterols, lipids and proteins occur within caveolae
and that investigating their molecular basis is necessary to
understand the structure and the multi-functional role of cav-
eolae.
A series of biochemical results have led to a consensus topo-
logical model of caveolin-1 although no direct structural infor-
mation is available [1,3 and references therein]. In particular,
three central domains have been identiﬁed: a limited intra-
membrane region L102–I134 ﬂanked at both N- and C-termini
by two amphipathic cytosolic segments D82–R101 and K135–
I150. Binding experiments and the presence of acylated cyste-
ines in the C-ter segment indicate that both amphipathic re-
gions constitute in-plane membrane anchors referred as N-
and C-attachment domains (N-MAD and C-MAD, respec-
tively) [1,4]. N-MAD, also named Caveolin Scaﬀolding Do-
main (CSD), has been identiﬁed as an essential element of
the interaction process between caveolin and proteins involved
in signal transduction [5]. It has to be pointed out that a num-
ber of these proteins are anchored to the membrane via either
acyl chains (Src kinases and G proteins, for example) or spe-
cialized domains such as the C2 domain of PKC and PLC.
In summary, the multi-functional role of the amphipathic
CSD is most likely largely determined through interaction net-
works occurring at the membrane interface.
CSD is thought to be involved in caveolin–cholesterol inter-
action through the presence of a particular motif found in its
sequence, V94-T-K-Y-W-F-Y-R101. As a result, this amino acid
distribution matches the cholesterol recognition amino-acid
consensus sequence (CRAC) consensus pattern pointed out
as an essential element of cholesterol binding process [6]. Sev-
eral data on the PBR protein and in particular a recent bio-
chemical and NMR study support the important role of the
CRAC sequence and provide structural elements on its func-
tion [7]. A recent study [8] has shown that the VTKYWFYR
peptide is able to promote the formation of cholesterol-rich
domains in the membrane. Quite interestingly, it has also been
shown that the CSD is able to recruit acidic phospholipids [9].
It has to be reminded that the membrane interface, i.e. the
region comprising the hydrated lipid polar heads, constitutes
a complex environment, highly heterogeneous both in terms
of chemical structure and dynamics [10], exhibiting singular
physico-chemical properties such as the well-known sharp gra-
dient of the dielectric constant. Elucidating the interaction net-
work driving lipid–caveolin association constitutes thus a
diﬃcult study, especially considering the scarce data relative
to lipid–protein interactions at the interface. In this context,
an appropriate method consists of studying by NMR caveolin
domains solubilized in membrane mimicking environmentsblished by Elsevier B.V. All rights reserved.
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(DPC) micelles [13] because of the presence of phosphocholine
head-groups.
The present paper reports on the CD and NMR studies of
two caveolin-1 fragments in the presence of perdeuterated
DPC micelles: D82–R101 strictly encompassing the CSD se-
quence and D82–I109, including the CSD plus eight residues
of the intra-membrane domain. The choice of the second pep-
tide was dictated by the presence in the middle of the CSD se-
quence of the TTFTVT motif. Such a quasi-continuous set of
b-branched residues constitutes a highly unfavourable pattern
for helical conformation supposed to be the predominant sec-
ondary structure of the central region of caveolin-1 [3] and is
also known to promote aggregation. To overcome this even-
tual diﬃculty, the CSD sequence was extended with the begin-
ning of the intra-membrane domain, that, in addition, provides
an hydrophobic anchor able to stabilize the peptide binding at
a membrane-like interface. In a second step, a set of NMR
experiments were performed using DPC micelles containing a
small amount of protonated phosphatidylserines.2. Materials and methods
2.1. Peptide synthesis
The peptides Cav-1 (82–101) and Cav-1 (82–109) were synthesized
by Ansynth Service B.V. (LE Roosendaal, NL). They were N-terminal
acetylated and C-terminal amidated. All peptides were puriﬁed to
>95% as judged by high-performance liquid chromatography and were
further characterized by matrix-assisted laser desorption ionization
time-of-ﬂight (MALDI/TOF) mass spectrometry.2.2. Circular dichroism
Far UV circular dichroism spectra were recorded on a Jobin-Yvon
CD6 spectropolarimeter calibrated with d-10-camphorsulfonic acid.
Measurements were performed at room temperature using 0.1 cm path
length quartz cuvettes (Hellma) for 17 lM Cav-1 (82–101) and 13 lM
Cav-1 (82–109) peptides solubilized in 10 mM sodium phosphate
buﬀer solutions containing 4 mM DPC. Spectra were recorded at
room temperature in the 185–260 nm wavelength range with a
0.5 nm step resolution, 2 s time constant and 2 nm bandwidth.
Spectra were averaged over four scans and corrected for background.
The concentration was determined by measuring the UV absorbance at
280 nm using appropriate extinction coeﬃcients for Trp and Tyr
residues [14]. A consensus secondary structure content was esti-
mated by spectral deconvolution using CONTINLL and CDSSTR
software and the data sets of reference proteins SMP50 (37 soluble
proteins and 13 membrane proteins) and SDP42 (42 soluble proteins)
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Fig. 1. CD spectra of 17 lM Cav-1 (82–101) and 13 lM Cav-1 (82–
109) peptides in 4 mM DPC micelles and 10 mM sodium phosphate
buﬀer (pH 6.2) at 25 C.2.3. NMR experiments
Samples were prepared using 1.2 mM Cav-1 (82–109) solubilized in
50 mM sodium phosphate buﬀer (pH 6.2) 90:10 H2O:D2O solutions
containing 200 mM of perdeuterated DPC-d38. NMR experiments
were performed at 20–45 C on DRX Bruker spectrometers operating
at 600 MHz and 800 MHz 1H frequency, equipped with a cryoprobe.
Chemical shifts were referenced to internal standard dimethylsilapen-
tane-sulfonic acid, sodium salt (DSS). Standard TOCSY and NOESY
spectra were recorded at 30 and 40 C with mixing times of 35, 50 and
70 ms (total correlated spectroscopy (TOCSY)), 150 and 300 ms (nu-
clear Overhauser eﬀect spectroscopy (NOESY) at 600 MHz) and 80
and 160 ms (NOESY at 800 MHz). Signal assignment was achieved
using the standard protocol [16]. For the 13C chemical shift assign-
ments, natural abundance 1H–13C HSQC spectra were recorded on a
1.2 mM peptide samples in 50 mM deuterated sodium phosphate buf-
fer (pH 6.2) at 30 and 40 C. To investigate peptide–lipid interactions,
POPS (Avanti Polar Lipids, Alabaster, AL) was added to a 1.2 mM
peptide sample in 50 mM deuterated sodium phosphate buﬀer (pH6.2) at a lipid to peptide ratio of 10. NOESY spectra in the presence
and absence of POPS were recorded at 30 C with mixing times of 100,
300 and 500 ms.3. Results and discussion
3.1. Structural analysis by CD spectroscopy
Fig. 1 shows the CD spectrum of the Cav-1 (82–101) and
Cav-1 (82–109) peptides in DPC micelles solution. The Cav-1
(82–101) spectrum exhibits a positive peak at approximately
191 nm and a negative peak at approximately 216 nm. Such
a proﬁle reﬂects the presence of a mixture of extended and heli-
cal conformations. In contrast, the Cav-1 (82–109) spectrum
exhibits a double minimum at around 208 and 222 nm, charac-
teristic of a predominant helical structure.
To determine the secondary structure contents of the pep-
tides from the CD spectra two diﬀerent methods, CONTINLL
and CDSSTR, were applied using two diﬀerent protein refer-
ence sets (see Section 2). An helical content of 32% was found
for the Cav-1 (82–101) peptide in the presence of DPC. Several
CD data on caveolin peptides including the CSD sequence
have been published and can be compared to our result. First,
our result is in agreement with the CD data relative to the Cav-
1 (83–101) peptide showing that the peptide only contains
‘‘some helicity’’ in the presence of SUVs [8]. Another CD study
concerns the Cav-1 (1–80) and Cav-1 (1–101) peptides in aque-
ous solution [17]. From the diﬀerence between the two corre-
sponding spectra on one hand and from structure prediction
on the other hand, the authors suggest that the residues 79–
96 form an a-helix, which represents an helix content of 75%
for the CSD motif. However, in this work, the helical second-
ary structure of the CSD sequence is indirectly deduced. Last,
in a very recent study [18], 33% triﬂuoroethyl alcohol (TFE), a
well-known helix promoter, was added to an aqueous solution
containing the Cav-1 (82–101) peptide. Observation of several
NH–NH (i, i + 1) NOEs in the corresponding NMR spectrum
is thought to be ‘‘consistent with a canonical a-helix between
residues 84 and 97’’, i.e. an helix content of 70%. The authors
indicate that the CD spectra obtained in the absence and pres-
ence of 33% TFE are identical. Our data obtained in the pres-
ence of DPC is thus not consistent with the last point. An
NMR study should provide more information. However, as
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Fig. 3. Chemical shifts indices obtained for the Ha protons (DdHa) (A)
and Ca carbons (DdCa) (B) of the Cav-1 (82–109) peptide solubilized in
DPC micelles.
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DPC aggregates at the concentration required for NMR stud-
ies.
In the case of the Cav-1 (82–109) peptide in DPC, the spec-
trum analysis gave an helix content of 64%, that is twice the
value deduced from the CD spectrum of the Cav-1 (82–101)
fragment. The helix content of Cav-1 (82–109) signiﬁcantly ex-
ceeds the value of about 50% obtained considering that the
helix content deduced for the Cav-1 (82–101) peptide is con-
served and that as an upper limit the eight additional residues,
102–109, form an a-helix. A plausible explanation is that the
membrane-like interface provided by the DPC micelles exerts
a signiﬁcant structuring eﬀect on the CSD conformation. How-
ever, a per residue conformational study is necessary to inves-
tigate this eﬀect, which was achieved from NMR data.
3.2. NMR characterization of the Cav-1 (82–109) peptide in
deuterated DPC micelles
At the mM concentration range, the Cav-1 (82–101) peptide
in DPC aggregates and thus could not be studied by NMR. As
mentioned in the introduction, the presence of the
T90TFTVT65 motif in the middle of the CSD sequence most
likely constitutes the main element that promotes aggregation.
In contrast, under the same concentration conditions, the Cav-
1 (82–109) peptide is readily soluble in the membrane-like envi-
ronment provided by DPC micelles and provides high quality
NMR spectra as illustrated by Fig. 2. This result may be re-
lated to the work of Brown and co-workers [19]. Proton reso-
nances of the Cav-1 (82–109) were assigned from standard
TOCSY and NOESY experiments recorded at 30 and 40 C.
All the chemical shifts of the backbone protons were obtained
except for the Ha protons of Thr 90, Thr 91 and Thr 95 and
the majority of the side-chains resonances were assigned.
Examination of the Ha chemical shift indices (CSI = DdHa,
Fig. 3A) highlights two main conformational features. First,
all the indices exhibit negative values thus attesting the pres-Fig. 2. Amide proton region of the 800 MHz NOESY spectrum of the
Cav-1 (82–109) peptide solubilized in DPC micelles (mixing time
160 ms, T = 30 C).ence of a predominant helical conformation. Second, the var-
iation of the DdHa amplitudes draws a noticeable proﬁle.
Discarding the two ﬁrst and three last residues of the sequence,
one can observe that the DdHa proﬁle displays a ﬁrst plateau
around an average value of about 0.17 ppm in the I84-F92
region. This plateau is followed by a sharp decrease of the in-
dex and a second plateau is observed around an average value
of 0.40 ppm in the T93-L106 region except for V94 and A105
(0.2 ppm). In order to minimize ring current and sequence
eﬀects on the secondary structure proﬁle, Ca CSI were deter-
mined. Most of the Ca chemical shifts were obtained except
for Thr 90, Thr 91 and Thr 95. As shown in Fig. 3B, the cor-
responding DdCa proﬁle is close to that drawn by the Ha indi-
ces except that the relative diﬀerence between the average
values of the two plateaus is signiﬁcantly increased. In the ab-
sence of NMR data relative to the Cav-1 (82–101) peptide, it is
however not possible to interpret the variation in helix content
observed by comparing the CD spectra of Cav-1 (82–101) and
Cav-1 (82–109). This variation can be due to an increase of the
helix proportion but also to an increase of stability.
Direct information on helix location can only be deduced
from the analysis of medium range NOEs. The sequential
and medium range NOEs involving the backbone protons
are reported on Fig. 4. The number of these NOEs appears rel-
atively limited due to several overlaps between the NH reso-
nances, even on the 800 MHz spectra, leading to ambiguous
NOEs. Nevertheless, from the NOE pattern, three regions
can be roughly distinguished: (i) the 84–88 and 93–97 segments
exhibiting a limited number of (i, i + 3) connectivities, (ii) the
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Fig. 4. Sequential and medium range NOE connectivities obtained for the Cav-1 (82–109) peptide solubilized in DPC micelles at 30 C from a 2D
NOESY spectrum (150 ms mixing time). The bar thickness refers to the NOE intensity (strong, medium, weak).
Fig. 5. Part of a NOESY spectrum (600 MHz, 300 ms, T = 30 C) of
the Cav-1 (82–109) peptide solubilized in DPC micelles showing the
ﬁngerprints of the CH2c or CH2e signals of the basic side chains of the
CSD in the absence (top) and presence (bottom) of POPS.
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(i, i + 3) NOEs; this region encompasses the hydrophobic
stretch added to the CSD, apart from the C-terminal I109 res-
idue. Combination of the CSI and NOE data indicates that the
Cav-1 (82–109) peptide exhibits two stable helix segments, 93–
97 and 102–108, and a more ﬂexible one, 83–88, at the N-ter-
minus. However, due to the limited set of unambiguous NOEs
concerning both the backbone and side chain protons, it was
not possible to obtain any description of the tertiary fold. Fur-
ther studies using a 15N labeled peptide would provide such
information.
Last, H/D exchange experiments were performed. A series of
NOESY spectra were recorded just after solubilization of the
peptide + DPC sample in a D2O solution. Most of the NH sig-
nals quickly disappear (in a few minutes) except for those of
the R101–F107 segment, still observed after several hours. This
result is in favor of the role of the C-terminal residues as an
anchor for the CSD to the membrane-like interface. In the fol-
lowing section, we report on the results of the study of the
Cav-1 (82–109) peptide in the presence of phosphatidylserine.
3.3. POPS-Cav-1 (82–109) peptide interactions
Protonated POPS was added to the sample containing the
Cav-1 (82–109) peptide solubilized in DPC micelles at a lipid
to peptide ratio of 10 and the corresponding 1D and 2D
spectra were compared to those obtained in the absence of lip-
ids. A ﬁrst interesting result of this comparison is that only a
limited number of residues detect the presence of POPS
through a chemical shift variation of their side chain protons.
This is illustrated by Fig. 5 showing a part of the NOESY spec-
trum containing the ﬁngerprint relative to the last methylene
protons of the three basic side chains of the CSD domain,
K86, K96 and R101. Whereas the CH2e signal of K86 is insen-
sitive to the presence of POPS, the CH2d signal of R101 and
the CH2e signal of K96 are shifted upﬁeld (Dd = 0.02 and
Dd(max) = 0.05 ppm, respectively). In addition to K96 and
R101, four other residues detect the presence of POPS through
a chemical shift variation of their side chain protons: V94,
Y97, Y100 and S104. The second interesting result of this
study is that the residues sensitive to POPS are located in a lim-
ited region of the peptide, containing the K96YWFYR101 mo-tif. However, no intermolecular NOE between lipid and
peptide protons can be observed suggesting a very short resi-
dence time of POPS at the contact with the peptide, at the
NOE time scale. It is thus not possible to obtain direct infor-
mation for docking PS molecules with respect to the peptide.
However, considering the anchoring interfacial properties of
the aromatic residues Trp and Tyr [20], we may assume that
the role of Y97, W98 and Y101 would be to insure an appro-
priate positioning of the two ﬂanking positively charge resi-
C.L. Lan et al. / FEBS Letters 580 (2006) 5301–5305 5305dues K96 and R101 in order to interact with the negatively
charged phosphate and carboxylic groups of POPS.
The present data constitute a ﬁrst step for elucidating at a
residue level the conformational properties of the central re-
gion of the caveolin protein and for understanding the mole-
cular basis underlying the role of its KYWFYR motif.Acknowledgements: We thank E. Guittet and N. Birlirakis (Institut de
Chimie des Substances Naturelles, Gif-sur-Yvette, France) for access
to a DRX 800 Bruker spectrometer and for technical support.References
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